Market Overview - A-shares experienced slight fluctuations around the previous day's closing levels, with major indices showing minor declines. The number of declining stocks significantly outnumbered advancing ones, while trading volume remained stable [1] - The Shenzhen Component Index decreased by 0.19% to 13,031.26, the Shanghai Composite Index fell by 0.09% to 3,894.22, and the ChiNext Index dropped by 0.50% to 3,055.92 [2] Electricity Sector - The electricity sector showed strong performance, with the sector index rising for the fifth consecutive day. Companies like Huadian Power and Mindong Electric reached their daily price limits shortly after the market opened [4] - The National Development and Reform Commission has revised several pricing methods related to electricity transmission and distribution, which may impact future pricing and cost assessments [6][7] - The International Energy Agency predicts that global electricity demand will double for data centers by 2030, with significant growth driven by electric mobility and artificial intelligence [7] - UBS forecasts that China's electricity demand growth rate will increase to 8% from 2028 to 2030, indicating a potential electricity supercycle lasting 5-10 years [8] Pharmaceutical Sector - The pharmaceutical retail sector has shown significant strength, with seven out of the last eight trading days seeing gains. Companies like Haiwang Bio and Ruikang Pharmaceutical have experienced rapid price increases [10] - The recent surge in flu cases has led to a sharp increase in sales of antiviral medications, with sales of Oseltamivir rising by 237% and other related medications seeing over 50% growth [14][15] - The market for antiviral medications in China is projected to reach 26.9 billion yuan by 2028, with a compound annual growth rate of 20.2% [16]
1分钟，垂直涨停，000078六连板